Ken Griffin Horizon Therapeutics Public LTD CO Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $27 Million - $31.6 Million	-273,100 Reduced 22.55%	937,800 $108 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $115 Million - $134 Million	1,193,200 Added 6741.24%	1,210,900 $125 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $28.5 Million - $30.2 Million	-265,900 Reduced 93.76%	17,700 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $13.9 Million - $25.3 Million	222,700 Added 365.68%	283,600 $32.3 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $2.36 Million - $3.4 Million	-40,100 Reduced 39.7%	60,900 $3.77 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.